key: cord-0046188-8hulkmab authors: Hart, C. Anthony title: Introduction to Acute Infective Diarrhoea date: 2020-06-22 journal: Manson's Tropical Diseases DOI: 10.1016/b978-1-4160-4470-3.50054-9 sha: e6b5f99b9748eadcd0c0f520bfc9449875e3e8b1 doc_id: 46188 cord_uid: 8hulkmab nan Diarrhoeal disease is a major cause of morbidity and mortality worldwide. In a global estimate of causes of death in 1990, diarrhoeal disease was the fourth commonest after ischaemic heart disease (6.25 million deaths), cardiovascular disease (4.4 million) and respiratory tract infections (4.3 million). 1 It was responsible for approximately 3 million of the total 50.5 million deaths. Although the burden of diarrhoeal disease is greatest in children under 5 years, and especially in developing countries, causing approximately 2 million deaths per annum, 2 adults and especially the elderly are also at risk. In general, viral enteropathogens are more important in childhood gastroenteritis in developed and developing countries alike, whereas bacterial and protozoal enteropathogens predominate in adults. 3 In developing countries, estimates of the annual incidence of diarrhoea in children vary from 3.3 episodes, 4 to 7.9 episodes, 5 to 10 episodes in urban Lima, Peru. 6 In contrast, the incidence is much less in children in developed countries. For example, children in Winnipeg, Canada, were reported to experience 0.8 diarrhoeal episodes per year, 7 and the overall incidence for all ages in Holland was also 0.8 per annum. 8 The contrast between paediatric diarrhoea in developed and developing countries is shown in Table 50 .1. The relative importance of the various viruses, bacteria and protozoa in developing and developed countries is shown in Table 50 .2. However, it must be remembered that the relative importance of the various enteropathogens will depend on a variety of factors, including the pathogens sought and the sensitivity and specifi city of the diagnostic tools used, the age group studied, the duration and season of study, geographical location, and whether the survey is hospital or community based. For example, improved diagnostic methods have increased the detection rates of astrovirus and caliciviruses (noroviruses and sapoviruses) and, in community-based studies, astrovirus, which causes a milder diarrhoea, assumes greater importance than rotavirus, 10 which is the converse to the situation in hospital-based studies. In addition to the morbidity and mortality associated with diarrhoeal disease, it is also a major drain on health resources in developing countries. For example, in Indonesia it was estimated that US$2.50 was spent per annum per child on diarrhoeal disease, against a yearly per capita health budget of US$5.41 at 1990 costs. There are over 40 different enteropathogens able to cause gastroenteritis and even in the best-funded laboratories not all are sought. To arrive at an aetiological diagnosis in all cases is neither possible nor necessary, except for epidemiological purposes, for example when a vaccine has been introduced, or when large epidemics occur. However, it is possible to subdivide diarrhoeal disease into two major categories, infl ammatory and noninfl ammatory. There are of course areas of overlap, but this classifi cation does provide a framework for discussing diarrhoeal disease (Table 50. 3). In addition to those in Table 50 .4, there are enteropathogens that produce vomiting with no or very little diarrhoea. This usually results from ingestion of emetic toxins liberated by certain strains of Staphylococcus aureus or Bacillus cereus. The pathogens causing non-infl ammatory diarrhoea are shown in Table 50 .4. For the majority of these, their principal site of action is the upper small intestine. Since the transit time is so rapid through the small intestine, an important pathogenic factor is the ability to adhere to the small-intestinal mucosa. The mechanisms most commonly employed in producing diarrhoea are osmotic and secretory. In the former there is an inability to degrade, for example disaccharides to monosaccharides. Since only monosaccharides can be absorbed by enterocytes, the disaccharides pass down the intestine, taking water with them. In secretory diarrhoea the enterocyte is stimulated to secrete fl uid into the gut lumen. Although there is some overlap (e.g. Salmonella spp. and Campylobacter spp. can both cause non-infl ammatory diarrhoea), the pathogens causing infl ammatory diarrhoea form a distinct group (Table 50 .4). Their site of action is usually the distal ileum and colon and they produce disease by destroying parts of the enteric mucous membranes, leading to an infl ammatory response. This in turn leads to the excretion of neutrophils and erythrocytes in faeces, which can be detected by simple wet fi lm microscopy or myeloperoxidase by ELISA. The prevalence of different enteropathogens varies with the age of the individual, how the diarrhoea is acquired (e.g. food poisoning or traveller's diarrhoea), between acute and chronic diarrhoea, and with the state of the host's immunity (Table 50. 2). In general, paediatric diarrhoea is most often due to viral enteropathogens (see Chapter 45) . Up to 60% of cases in most hospital-based surveys are due to viruses, with rotavirus accounting for a large proportion of cases, followed by adenovirus 40/41 and then astrovirus, but it is now clear that noroviruses are important causes of outbreaks of disease. Bacterial enteropathogens such as enteropathogenic Escherichia coli (EPEC), enteroinvasive E. coli (EIEC), enterotoxigenic E. coli (ETEC), enteroaggregative E. coli (EAggEC), salmonellae, Campylobacter jejuni and shigellae and the protozoan Cryptosporidium parvum and C. hominis are responsible for the majority of the remaining cases where a pathogen is found. In adults, bacteria assume greater importance, although viral gastroenteritis does occur, due, for example, to unusual serogroups of rotavirus, norovirus or astrovirus. 18, 19 For instance, it is estimated that C. jejuni is responsible for 17-20% of episodes of adult diarrhoea. In temperate countries, viruses, except for noroviruses, produce peaks of disease in the cold dry weather of winter, 20 whereas in tropical Africa the seasonality is blurred but with an upsurge in cases in the dry season. 21 In contrast, bacterial and protozoal diarrhoeas tend to occur in the wetter seasons in the tropics and summer in temperate countries. In temperate countries, cryptosporidiosis peaks in spring with a lesser peak in autumn, but, for example, in Gaza, most cases occur in the hottest and driest parts of the year, perhaps when water availability and quality is compromised. 22 On a more global scale, during the 1997-1998 El Nino, when mean ambient temperatures were 5°C higher than normal, in Peru the number of daily hospital admissions with gastroenteritis doubled. 23 Diarrhoeal disease following ingestion of food or water contaminated by bacteria, toxins or protozoa is still an important problem in both developed and developing countries. Although high-intensity animal rearing is important in the maintenance of human enteropathogens in developed countries, in developing countries human-derived enteric pathogens such as Salmonella spp. and C. jejuni and enterohaemorrhagic E. coli (EHEC) may still be implicated in outbreaks of food poisoning. Recently, water-borne outbreaks of C. parvum have been assuming greater importance. It is estimated that approximately 16 million people will travel annually from their domicile in industrialized countries to less-developed countries. Approximately one-third of these will develop diarrhoeal disease and in the majority of cases this will be due to an infective agent. 24 A large number of different enteropathogens have been implicated, but in most surveys ETEC are the predominant pathogens (Table 50 .5), followed by C. jejuni and Salmonella spp. The aetiological agents vary considerably according to the countries visited; for example, C. parvum and C. hominis have recently been shown to be important in visitors to the Caribbean 25 and Africa. 26 Viral enteropathogens can cause traveller's diarrhoea but have, for example, been more frequently associated with shipboard epidemics, in which astrovirus and norovirus have been implicated. In tropical countries, the immune compromises due to malnutrition and HIV are of major importance; both affect the frequency Epidemiological Aspects and severity of diarrhoeal disease. With the appearance of AIDS, diarrhoeal disease due to previously unrecognized pathogens, such as C. parvum, Isospora belli, Enterocytozoon bieneusi and Mycobacterium avium-intracellulare, has assumed increasing importance, albeit more often causing chronic diarrhoea. 27 Interestingly, rotavirus-the major cause of infantile gastroenteritis-appears to be no more severe in HIV-infected than in HIV-uninfected children. 28 The mainstay of management of diarrhoeal disease is the assessment of dehydration (Figure 50 .1) and the appropriate replacement of fl uid and electrolytes. 29 Although diarrhoeal disease can produce dehydration at any age, its impact is greatest in those under 5 years old. This is because, as a result of their relatively greater surface area and thus greater fl uid loss through skin, infants require 2.5 times more water per kilogram body weight than older individuals. Fluid and electrolyte loss is also greatly exacerbated by vomiting. Both the initial degree of dehydration and the response to rehydration therapy should be monitored clinically (Table 50.6) . Originally, rehydration was exclusively intravenous. This resulted in a tremendous drop in fatality rates -for example, in cholera, from 40% to less than 1% when properly administered. A major advance was made when an effective oral rehydration regimen was devised. Early oral rehydration solutions (ORS) contained only electrolytes and water and it was not until it was realized that glucose or sucrose was required to enhance sodium absorption that effective oral rehydration therapy became available. Glucose and sodium transport into enterocytes are coupled. Sucrose, a dimer of glucose and fructose, must be cleaved by brush-border sucrase for it to be absorbed. Nevertheless, glucose and sucrose seem to be equally effective in ORS, 30 although there may be minor advantages with glucose. 31 There is also some debate over the use of bicarbonate or citrate to correct acidosis. Both are equally effective, but citrate is more stable and has replaced bicarbonate in World Health Organization (WHO) solutions. A further modifi cation has been the incorporation of glycine, which is taken into the enterocyte by a specifi c amino acid transport system. Glycine, when present in ORS at a concentration of 111 mmol/L, was found to decrease both duration of diarrhoea and stool volume. 32 The composition of various ORS is shown in Table 50 .7. ORS can be obtained in packets from UNICEF or can be made up locally. They should contain sodium chloride (3.5 g), potassium chloride (1.5 g) and glucose monohydrate (22 g), made up to 1 L with potable water (sucrose, 40 g, may replace glucose, and trisodium citrate dehydrate, 2.9 g, sodium bicarbonate). To be fully effective ORS should be available at the village level so therapy can be initiated as rapidly as possible. This will require the solution(s) to be available either prepacked or in bulk, with appropriate measuring spoons, a method of providing the correct volume of potable water, and instructions on use as well as to discard unused solution within 24 hours. Studies have shown that when properly instructed 98% of mothers can prepare ORS with a sodium range of 30-110 mmol/L. 33 Recently, rice powder-based ORS have been investigated, since these are more readily available. Rice powder at 30-50 g/L is an effective substitute for glucose. It tastes better than simple electrolyte-glucose ORS and is thus more acceptable to children. A recent meta-analysis of 13 randomized trials of rice-based versus glucosebased oral rehydration therapy demonstrated the superiority of the rice-based solution in cholera diarrhoea, although the benefi t was considerably smaller for children with acute non-cholera diarrhoea. 34 During the initial phase of oral rehydration therapy, while the patient is dehydrated, adults can consume 750 mL/h and children up to 300 mL/h. Maintenance therapy of 20 mL solution per kilogram body weight should be started as soon as signs of dehydration have gone. ORS are suitable for rehydration of all except severely dehydrated infants and those with shock (Table 50 .8). Decreased-osmolarity ORS (178-268 mmol/L) has been shown to be as safe and effective as conventional ORS (311 mmol/L). 35 Approximately 98% of children will respond to oral rehydration therapy. The remainder are generally infants with severe dehydration or those with profuse vomiting or a high purging rate. These will require rehydration by the intravenous route. Suitable solutions include: Ringer's lactate (Hartman's), consisting of NaCl 6.2 g, KCl 0.4 g, Na lactate 2.3 g and 2 mL 50% glucose per litre of solution; Dacca solution (NaCl 5 g, NaHCO 3 4 g, KCl 1 g and 2 mL 50% glucose per litre of solution); or acetate solution (NaCl 5 g, KCl 1 g, Na acetate 6.5 g and 2 mL 50% glucose per litre of solution). Oral rehydration therapy should be started as soon as possible following institution of intravenous rehydration; however, if signs of severe dehydration persist, it may be necessary to continue using Ringer's lactate at 100 mL/kg body weight per 4 hours. Other potential therapeutic interventions include antimicrobial agents, antimotility drugs and antisecretory drugs. They have varying degrees of effi cacy and some are absolutely contraindicated for certain conditions. In general, infants with acute watery diarrhoea are best managed without recourse to antibiotics. However, if there is evidence of systemic spread, cholera or dysentery, then antimicrobials will shorten the course of diarrhoea and ameliorate its effects. With the advent of the fl uoroquinolones such as ciprofl oxacin and ofl oxacin, the debate on the use of antimicrobials has been reopened. First, there is no doubt that the widespread indiscriminate use of antimicrobials, often in subtherapeutic regimens, encourages resistance in both pathogens and normal enteric fl ora. 36 On the other hand, even with ETEC, early treatment with co-trimoxazole 37 or ciprofl oxacin can decrease the severity of diarrhoea. This is preferred to the widespread prophylactic use of these antimicrobials, which will certainly produce resistant bacteria. In cholera, tetracycline or ciprofl oxacin decreases the duration of diarrhoea and shedding of bacteria. In countries where Shigella spp. dysentery is endemic or when epidemics occur, antimicrobials are of benefi t, but development of resistance during the course of epidemics occurs with monotonous regularity. 36 Metronidazole (or tinidazole) is valuable in the treatment of giardiasis or amoebic dysentery. These should be avoided. These will of course only be effective if there is a secretory component to the diarrhoea. The value of loperamide as an adjunct in treating diarrhoea in well-nourished children has been demonstrated 38 but these authors warned against its use in malnourished children. Compounds such as kaolin or charcoal which, it is postulated, act by absorbing toxins, have had little effect in controlled trials. Micronutrient defi ciencies have been associated with increased incidence, severity and duration of diarrhoeal and other diseases. Micronutrient supplementation trials have yielded varying results. For example, a trial of vitamin A supplementation in Haiti demonstrated an increased 2-week prevalence of diarrhoea post supplementation, 39 whereas a trial of zinc supplementation in India has demonstrated clinically important decreases in the severity and duration of diarrhoea. 40 There is increasing interest in the value of administering commensal bacteria (probiotics) to ameliorate diarrhoeal disease. 41 In trials in Pakistan and Thailand, administration of one such probiotic, Lactobacillus casei GG, decreased the duration of diarrhoea and reduced stool frequency in children with acute watery diarrhoea. 42, 43 In industrialized countries, it has been the separation of human and animal excreta from potable water and foodstuffs that has contributed to the great decline in the incidence of diarrhoeal disease. In addition, improvements in facilities for personal hygiene within the home have decreased the intrafamilial spread of enteropathogens. To implement these measures in developing countries will need a massive input from industrialized countries. Other simpler and more locally applicable measures to prevent diarrhoeal disease include development of technologies and practices that interrupt disease transmission by muscid fl ies. 44, 45 Recently it has been shown that exposure of drinking water (in plastic bottles) to tropical sunlight decreased diarrhoeal disease in Maasai children in Kenya. 46 There is little doubt that measles and malnutrition increase the morbidity and mortality of diarrhoeal disease, and control of measles by immunization should be possible. Finally, it is unlikely that spread of some enteric pathogens, such as rotavirus, can be prevented completely by public health and good hygiene. A safe and effective vaccine would be of major benefi t. Malnutrition greatly affects immunity 47, 48 and the incidence and severity of diarrhoeal disease. Similarly, diarrhoeal disease will greatly exacerbate malnutrition, thus creating an inexorable downward spiral. Acute diarrhoeal disease can become chronic, and chronic diarrhoea, for example that due to C. parvum or C. hominis, can become greatly prolonged. 49 Disaccharide (principally lactose) intolerance following certain types of diarrhoea has been a source of great controversy. Certain pathogens such as rotavirus or EPEC produce a great decrease in small-intestinal disaccharidase levels. Some consider that infants should not be given their normal diet because of the problem of disaccharide intolerance. Most evidence now suggests that infants should return to their normal diet within 24 hours of onset of diarrhoea unless there are specifi c contraindications. 50 Diarrhoeal disease is still a major cause of mortality even though it has been shown that introduction of oral rehydration therapy can decrease mortality to less than 0.5% in defi ned study areas. Editors regret to announce the untimely death of Professor Tony Hart whose contributions to Manson's were invaluable. Mortality by cause for eight regions of the world: global burden of disease study The magnitude of the global problem of diarrhoeal disease: a ten year update Diagnosis and causes of viral gastroenteritis WHO/CDD/VID/84.4 Diarrhoeal Disease Control Programme. Report of the Third Meeting of the Scientifi c Working Group on Viral Diarrhoeas. Microbiology, Epidemiology, Immunology and Vaccine Development Epidemiology of rotavirus in cohort of 45 Guatemalan Mayan Indian children from birth to age 3 year Incidence and etiology of infantile diarrhea and major routes of transmission in Huascar, Peru A prospective study of rotavirus infection in infants and young children Gastroenteritis in sentinal practices Pediatric diarrheal diseases: a global perspective Population-based prevalence of symptomatic and asymptomatic astrovirus infection in rural Mayan infants Etiology of acute diarrhoea among children in developing countries: a multicentre study in fi ve countries Viral diarrhea in children in Beijing Non-bacterial diarrhoea in children in the Philippines Viral gastroenteritis in children in Malawi Human torovirus: a new nosocomial gastrointestinal pathogen Prevalence of astrovirus infection among Chilean children with acute gastroenteritis Etiology of acute gastroenteritis in hospitalized children in Melbourne Emergence of adult diarrhoea rotavirus in Calcutta, India The changing epidemiology of astrovirusassociated gastroenteritis: a review Viral gastroenteritis Epidemiology of rotavirus diarrhoea in Africa: a review to assess the need for rotavirus immunization Cryptosporidiosis in children in Gaza Effects of El Nino and ambient temperature on hospital admissions for diarrhoeal diseases in Peruvian children Epidemiology of diarrhea in travellers Cryptosporidium in tourists returning from the Caribbean Cryptosporidium: traveller's diarrhea in two families Gastrointestinal infections in AIDS Effect of concomitant HIV infection on presentation and outcome of rotavirus gastroenteritis in Malawian children Oral rehydration therapy Oral rehydration in rotavirus diarrhoea: a double blind comparison of sucrose with glucose electrolyte solution Comparison of sucrose with glucose in oral therapy of infant diarrhoea In search of a super oral rehydration solution: can optimum use of organic solute-mediated sodium absorption lead to the development of an absorption promoting drug? Evaluation of the oral therapy expansion program (OTEP) of the Bangladesh rural advancement committee (BRAC) Impact of rice based oral rehydration solution on stool output and duration of diarrhoea: meta-analysis of 13 clinical trials Reduced osmolarity oral rehydration solution for treating cholera Global aspects of antimicrobial resistant enteric bacteria Treatment of traveller's diarrhea with trimethoprim/sulfamethoxazole and with trimethoprim alone Loperamide in acute diarrhoea in childhood: results of a double blind placebo controlled multicentre clinical trial Vitamin A supplementation and increased prevalence of childhood diarrhoea and acute respiratory infections Zinc supplementation in young children with acute diarrhea in India Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefi t health? Lactobacillus GG promotes recovery from acute non-bloody diarrhea in Pakistan Lactobacillus GG and acute diarrhoea in young children in the tropics Impact of fl y control on childhood diarrhoea in Pakistan: community randomised trial Effect of the fl y control on trachoma and diarrhoea Solar disinfection of drinking water and diarrhoea in Maasai children: a controlled fi eld trial Nutrition, immunity and infection: present knowledge and future directions The infl uence of undernutrition on immunity Cryptosporidium, malnutrition and chronic diarrhea in children Use of oral fl uid therapy and posttreatment feeding following enteritis in children in a developed country